• NIFTY  
    11,661.85
    (0.65%)
  • SENSEX  
    39,298.38
    ( 0.63%)
  • USDINR  
    70.99
    ( -0.36%)
  • GOLD  
    38,090.00
    ( -0.28%)
Earum Pharmaceuticals Ltd
  • Registered Office: G1 Ground Floor VR Complex,Nr Sanathal Cross Rd SP RingRd, Ahmedabad - 382210, Gujarat, India. Phone : 91-79-48402525   Fax:
  • Email : cs@earumpharma.com
  • Website :www.earumpharma.com
Initial Public Offer of 18,48,000 equity shares of face value of Rs.10 each (the "equity shares") of Earum Pharmaceuticals Limited ("the company" or "epl" or "the issuer") at an issue price of Rs.36 per equity share for cash, aggregating up to Rs. 6.65 Crores ("public issue") out of which 96,000 equity shares of face value of Rs. 10 each, at an issue price of Rs. 36 per equity share for cash, aggregating Rs. 0.35 Crores will be reserved for subscription by the market maker to the issue (the "market maker reservation portion"). the public issue less market maker reservation portion i.e. issue of 17,52,000 equity shares of face value of Rs. 10 each, at an issue price of Rs. 36 per equity share for cash, aggregating upto Rs. 6.31 Crores is here in after referred to as the "net issue". the public issue and net issue will constitute 29.96% and 28.41 % respectively of the post issue paid-up equity share capital of the company. The face value of the equity share is Rs.10 each. Fixed Price issue at Rs.36 per share and is 3.6 times of the face value.
Issue
Opens On Closes On
21-Jun-19 26-Jun-19
Money Payable On
Application Allotment
36.00 0.00
Minimum Application for shares in Nos : 3000 Further Multiples of : 3000
Cr Lead Managers to the Issue
Project Cost (.Cr) 6.65 Hem Securities Ltd
Project Financed through Current Offer (.Cr) 6.65  
Post Issue Equity Share Capital (.Cr) 6.17
Issue Price () 36.00
Projects
To Meet Working Capital Requirements
General Corporate Purpose
Promoted By
Bhumishth Narendrabhai Patel
Payal Bhumishth Patel
Listing At
BSE - SME
Registrar to the Issue
Bigshare Services Pvt Ltd
 

Useful Links

Back to Top
Attention Investors
Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day.............issued in the interest of investors. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account                                    "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
Investors should be cautious of unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website.BSE   http://www.bseindia.com/investors/tip-off-registration.aspx?expandable  NSE   https://www.nseindia.com/int_invest/dynacontent/any_portal.htm
All payments to Stock Broker shall be received from the market intermediaries/participants strictly by account payee crossed cheques / demand drafts or by way of direct credit into the bank account through electronic fund transfer, or any other mode permitted by the Reserve Bank of India. Stock Brokers shall not accept cash from their clients either directly or by way of cash deposit to the Bank Account of Stock Broker.
Group Companies Members of : BSE, NSE, MCX, MCX.SX, CDSL, NCDEX, Broking Services, Depository Services, Portfolio Management Services, Member Area IPO Distribution, Insurance Broking
BSE Clearing No.: 911 | SEBI Regn. No.: INZ000177531 (Cash/F&O) | NSE Clearing No.: 11858 | SEBI Regn. No. INZ000177531 (Cash/F&O/CDs) | MCX-SX Clearing No.: 11400 | SEBI Regn. No.: INZ000177531 (CDs) | CDSL DP ID: 30300 | SEBI Regn. No.: IN-DPCDSL-210-2003 | MCX SEBI Reg No.: INZ000032336 | MCX: 10665 | NCDEX: 00254 | NBFC RBI Regn. No.: 13.01851
© Copyright 2018 Ajmera Associates Ltd ( ISO 9001:2015 Certified )
Designed, Developed and Powered By CMOTS Infotech ( ISO 9001:2015 Certified )
Open An Account Today !